Literature DB >> 17900709

Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes.

Daniel A Nelson1, Melanie D Tolbert, Sam J Singh, Kenneth L Bost.   

Abstract

Trace amines such as tyramine, octopamine and beta-phenylethylamine bind with high affinity to the mammalian trace amine-associated receptor 1 (Taar1), potentially activating G-proteins in the synaptic membranes of target neurons. Recently there has been significant interest in Taar1, since this receptor can bind certain psychoactive drugs of abuse such as Ecstasy (3,4-methylenedioxymethamphetamine). Surprisingly, Ecstasy has been shown to alter responses of immune cells, and we questioned whether Taar receptors might be responsible for this effect. Using sensitive and quantitative RT-PCR assays, we found no detectable expression of Taar mRNA in bone marrow, or in primary cultures of mouse macrophages and dendritic cells whether quiescent or activated by exposure to lipopolysaccharide or the mouse gamma herpesvirus-68 (gammaHV-68). Mouse B cells and NK cells isolated from spleen, however, showed expression of several Taar mRNA species. Taar mRNA expression was also upregulated in human peripheral blood lymphocytes following in vitro stimulation with PHA. These studies represent the first to define expression of the mRNAs encoding these trace amine receptors in leukocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900709      PMCID: PMC2189554          DOI: 10.1016/j.jneuroim.2007.08.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  54 in total

1.  Following the trace of elusive amines.

Authors:  R T Premont; R R Gainetdinov; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

2.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

3.  Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans.

Authors:  R Pacifici; P Zuccaro; M Farré; S Pichini; S Di Carlo; P N Roset; J Ortuño; M Pujadas; A Bacosi; E Menoyo; J Segura; R de la Torre
Journal:  Life Sci       Date:  2001-11-02       Impact factor: 5.037

Review 4.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

5.  Trace amines: identification of a family of mammalian G protein-coupled receptors.

Authors:  B Borowsky; N Adham; K A Jones; R Raddatz; R Artymyshyn; K L Ogozalek; M M Durkin; P P Lakhlani; J A Bonini; S Pathirana; N Boyle; X Pu; E Kouranova; H Lichtblau; F Y Ochoa; T A Branchek; C Gerald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

6.  Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge.

Authors:  T J Connor; J P Kelly; M McGee; B E Leonard
Journal:  Life Sci       Date:  2000-08-18       Impact factor: 5.037

7.  Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production.

Authors:  T J Connor; D B Connelly; J P Kelly
Journal:  Immunol Lett       Date:  2001-09-03       Impact factor: 3.685

Review 8.  Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings.

Authors:  R Pacifici; P Zuccaro; M Farré; S Pichini; S Di Carlo; P N Roset; I Palmi; J Ortuño; E Menoyo; J Segura; R de la Torre
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 9.  Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.

Authors:  Kelly M Smith; Lisa L Larive; Frank Romanelli
Journal:  Am J Health Syst Pharm       Date:  2002-06-01       Impact factor: 2.637

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  27 in total

1.  Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Authors:  Gregory M Miller
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

2.  Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.

Authors:  Irma E Cisneros; Anuja Ghorpade
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

Review 3.  TAAR Agonists.

Authors:  Zhengrong Xu; Qian Li
Journal:  Cell Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.046

4.  Evidence for functional trace amine associated receptor-1 in normal and malignant B cells.

Authors:  Agata M Wasik; Mark J Millan; Thomas Scanlan; Nicholas M Barnes; John Gordon
Journal:  Leuk Res       Date:  2011-10-27       Impact factor: 3.156

Review 5.  Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs.

Authors:  Angela R Ozburn; Aaron J Janowsky; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2015-10       Impact factor: 3.455

6.  Trace amine associated receptor 1 signaling in activated lymphocytes.

Authors:  Michael W Panas; Zhihua Xie; Helen N Panas; Marius C Hoener; Eric J Vallender; Gregory M Miller
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-29       Impact factor: 4.147

7.  Minimal Age-Related Alterations in Behavioral and Hematological Parameters in Trace Amine-Associated Receptor 1 (TAAR1) Knockout Mice.

Authors:  I S Zhukov; L G Kubarskaya; I Y Tissen; A A Kozlova; S G Dagayev; V A Kashuro; O L Vlasova; E L Sinitca; I V Karpova; R R Gainetdinov
Journal:  Cell Mol Neurobiol       Date:  2019-08-09       Impact factor: 5.046

8.  Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression.

Authors:  Daniel A Nelson; Jamie L Nirmaier; Sam J Singh; Melanie D Tolbert; Kenneth L Bost
Journal:  Brain Behav Immun       Date:  2008-02-15       Impact factor: 7.217

Review 9.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 10.  International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature.

Authors:  Janet J Maguire; William A E Parker; Steven M Foord; Tom I Bonner; Richard R Neubig; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.